查看购物车
  • Traditional Chinese
  • English
  • Japanese
封面
市场调查报告书
商品编码
1696251

全球维生素和矿物质市场 - 2025 至 2032 年

Global Vitamins and Minerals Market - 2025-2032
出版日期: | 出版商: DataM Intelligence | 英文 180 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

简介目录

2024 年全球维生素和矿物质市场规模达到 226.8 亿美元，预计到 2032 年将达到 345.9 亿美元，2025-2032 年预测期内的复合年增长率为 5.42%。

人体的多种发育都需要维生素和矿物质。摄取足量的矿物质可以改善情绪并减轻压力。它们可以强健骨骼、癒合伤口并增强免疫系统。它们还将食物转化为能量并修復细胞损伤。维生素和矿物质缺乏会削弱免疫系统并导致多种疾病。

年轻人为了实现美学目标的健康意识不断增强，以及人们对均衡饮食必要性的认识，推动了维生素和矿物质补充剂市场的兴起。全球超过 60% 的消费者每天都使用维生素，约 55% 的消费者被说服摄取补充剂以维持健康的生活方式。消费者对优惠的信心和信念以及消费能力的提高为高端品牌在 2022 年及以后的扩张创造了各种机会。

动态的

健康意识不断增强

维生素缺乏会导致我们身体出现多种疾病。维生素C缺乏会导致坏血病，而维生素A缺乏会导致夜盲症。身体出现肌肉无力和骨骼不适最常见的原因是维生素缺乏。毋庸置疑，如今大量成年人口都在办公室工作，单靠饮食无法满足每日的营养需求。同样，消费者正在采取一种整体的生活方式来提高他们的生活效率。

因此，人们对人类营养和预防性保健意识的增强正在推动全球对维生素和矿物质补充剂的需求。由于忙碌的生活方式和食物准备过程中营养的流失而导致的维生素缺乏症的普遍存在可能会诱使消费者使用维生素和矿物质补充剂。

世界卫生组织（WHO）估计，全球有超过20亿人患有微量营养素缺乏症。各年龄层的膳食补充剂使用量增加了 70%。此外，强烈建议孕妇和 40 岁以上的妇女补充维生素和矿物质。营养不良率较高的国家，如塞拉利昂、赖索托、阿富汗和奈及利亚，可能为维生素和矿物质产业带来潜力。

供应链约束和原物料价格波动

全球维生素和矿物质市场的一个主要限制因素是原材料价格的波动和供应链中断。维生素和矿物质的生产依赖于抗坏血酸（维生素 C）、生育酚（维生素 E）和各种矿物盐等关键成分，这些成分主要来自中国、印度和其他亚洲国家。

由于监管限制、贸易政策或地缘政治紧张局势导致的原材料供应的任何波动都可能影响全球供应。例如，2023 年，中国对化学品製造实施了更严格的环境法规，导致维生素 C 和 B 群维生素的生产成本上升。这导致供应短缺和价格上涨，影响了全球补充剂製造商。

目录

第 1 章：方法与范围

第 2 章：定义与概述

第 3 章：执行摘要

第 4 章：动态

  • 影响因素
    • 驱动程式
      • 健康意识不断增强
    • 限制
      • 供应链约束和原物料价格波动
    • 机会
    • 影响分析

第五章：产业分析

  • 波特五力分析
  • 供应链分析
  • 定价分析
  • 监管分析
  • 可持续性分析
  • DMI 意见

第 6 章：按产品

  • 维生素
    • 维生素A
    • 维生素B
    • 维生素C
    • 复合维生素
    • 其他的
  • 矿物质
    • 锌
    • 钙
    • 其他的
  • 多种维生素/矿物质 (MVM) 补充剂

第 7 章：按配销通路

  • 医院药房
  • 零售药局
  • 网上销售
  • 其他的

第 8 章：按形式

  • 胶囊
  • 平板电脑
  • 粉末
  • 咀嚼片
  • 其他的

第九章：按地区

  • 北美洲
    • 我们
    • 加拿大
    • 墨西哥
  • 欧洲
    • 德国
    • 英国
    • 法国
    • 义大利
    • 西班牙
    • 欧洲其他地区
  • 南美洲
    • 巴西
    • 阿根廷
    • 南美洲其他地区
  • 亚太
    • 中国
    • 印度
    • 日本
    • 澳洲
    • 亚太其他地区
  • 中东和非洲

第 10 章：竞争格局

  • 竞争格局
  • 市场定位/份额分析
  • 併购分析

第 11 章：公司简介

  • AMWAY
    • 公司概况
    • 产品组合和描述
    • 财务概览
    • 关键进展
  • Lonza Group
  • BASF SE
  • Koninklijke DSM NV
  • Du Pont
  • Pfizer Inc.
  • Nutrilo GmbH
  • AIE Pharmaceuticals
  • ParkAcre Enterprises
  • Aland (Jiangsu) Nutraceutical

第 12 章：附录

简介目录
Product Code: FB9406

Global vitamins and minerals market reached US$ 22.68 billion in 2024 and is expected to reach US$ 34.59 billion by 2032, growing with a CAGR of 5.42% during the forecast period 2025-2032.

Vitamins and minerals are needed for the body's development in a variety of ways. Mineral intake in sufficient amounts can improve mood and reduce stress levels. They strengthen the bones, heal wounds and boost the immune system. They also convert food to energy and heal cellular damage. Vitamin and mineral deficiencies can weaken the immune system and lead to a variety of disorders.

The growing health consciousness among young people to accomplish aesthetic goals, as well as people's understanding of the necessity of a balanced diet, is driving the rise of the vitamins and mineral supplements market. More than 60% of customers globally use vitamins daily, with approximately 55% persuaded to ingest supplements to maintain a healthy lifestyle. Consumers' confidence and belief in the benefits, as well as improved spending capacity, have created various chances for premium brands to expand in 2022 and beyond.

Dynamic

Growing Health Awareness

Vitamin deficiency causes a variety of ailments in our body. Vitamin C shortage results in scurvy, while vitamin A deficiency causes night blindness. The most prevalent cause of muscle weakness and bone discomfort in the body is vitamin deficiency. Needless to say, with a big adult population working in offices nowadays, a diet alone cannot provide daily nutritional requirements. Similarly, consumers are adopting a holistic lifestyle to increase productivity in their lives.

As a result, people's increased awareness of human nutrition and preventative healthcare is driving up global demand for vitamins and mineral supplements. The prevalence of vitamin deficiencies due to a hectic lifestyle and loss of nutrition during food preparation is likely to tempt consumers to use vitamins and minerals supplements.

The World Health Organization (WHO) estimates that there are over two billion cases of micronutrient deficiency worldwide. Dietary supplement usage has increased by 70% across all age groups. Also, vitamins and mineral supplements are highly suggested for pregnant women and those over the age of 40. Countries with greater malnutrition rates, such as Sierra Leone, Lesotho, Afghanistan and Nigeria, may present a potential for the vitamins and minerals sector.

Supply Chain Constraints and Raw Material Price Volatility

One major restraint in the global vitamins and minerals market is the volatility in raw material prices and supply chain disruptions. The production of vitamins and minerals depends on key ingredients such as ascorbic acid (Vitamin C), tocopherols (Vitamin E) and various mineral salts, which are heavily sourced from China, India and other Asian countries.

Any fluctuations in raw material availability due to regulatory restrictions, trade policies or geopolitical tensions can impact global supply. For example, in 2023, China imposed stricter environmental regulations on chemical manufacturing, leading to higher production costs for Vitamin C and B-complex vitamins. This resulted in supply shortages and price surges, affecting supplement manufacturers worldwide.

Segment Analysis

The global vitamins and minerals market is segmented based on product, distribution channel, form and region.

Multivitamin Capsules in the global market are expected to drive the market.

In 2024, the multivitamin capsules accounted for the largest percentage of the global vitamins and minerals market. Of all the vitamins and minerals, multivitamins are the most commonly ingested. These multivitamin tablets greatly assist the working population in meeting their daily nutritional requirements because the vitamins and minerals in these capsules can successfully relieve stress and depression symptoms. For example, Vitamin B promotes the neurological system to produce stress-relieving chemicals. Consuming enough vitamins and minerals might help the brain function and affect mood. According to a National Institute of Mental Health report, approximately 40% of Americans over the age of 50 take multivitamins.

A recent study found that taking a multivitamin or multimineral supplement on a regular basis or everyday improves cognition in older people over a three-year period. If verified by future investigation, these findings could provide a simple and cost-effective technique to decrease age-related memory loss, according to the researchers.

According to studies published in June 2023 by Brigham and Women's Hospital and Harvard Medical School, a multivitamin experiment showed surprisingly substantial effects on memory as we age. According to the 3,500 participants in the COSMOS-Web Study, who were aged 60 and older, taking a daily multivitamin reduced cognitive aging by 3.1 years compared to those who took placebos. COSMOS's second cognitive experiment, the clinical research, revealed that multivitamins may aid in minimizing memory loss.

Geographical Penetration

Growing Health Consciousness in North America

North America is expected to be the dominant region in the global vitamins and minerals market. The first multivitamin (MV) dietary supplements and multivitamin/mineral (MVM) were created in the early 1940s. MVMs, for example, are popular supplements; it is estimated that one-third of individuals in the United States already take them and one-fourth of children and teenagers do too. In the United States in 2019, MVMs and MVs accounted for 38% of all vitamin and mineral supplement sales and 14% of all supplement purchases. In 2020, the United States sold around US$ 55.7 billion in dietary supplements, with 21.2 billion coming from goods containing vitamins, minerals, or both and 8.0 billion coming from MVMs and MVs.

Multivitamins greatly assist the working population in meeting their daily nutritional requirements since the vitamins and minerals in this multivitamin pill can successfully relieve stress and depression symptoms. For example, vitamin B encourages the neurological system to create stress-relieving chemicals. Consuming vitamins and minerals in a suitable and appropriate method increases brain function and has a favorable effect on mood.

According to a poll performed by the National Institute of Mental Health, 40% of Americans over the age of 50 take multivitamin tablets. North America's healthcare system is progressively emphasizing preventive treatment to decrease the stress on the system. Vitamins and supplements are considered preventive measures, matching with this approach and supporting their use.

Competitive Landscape

The major global players in the market include AMWAY, Lonza Group, BASF SE, Koninklijke DSM N.V., Du Pont, Pfizer Inc., Nutrilo GmbH, AIE Pharmaceuticals, ParkAcre Enterprises and Aland (Jiangsu) Nutraceutical.

Why Choose DataM?

  • Data-Driven Insights: Dive into detailed analyses with granular insights such as pricing, market shares and value chain evaluations, enriched by interviews with industry leaders and disruptors.
  • Post-Purchase Support and Expert Analyst Consultations: As a valued client, gain direct access to our expert analysts for personalized advice and strategic guidance, tailored to your specific needs and challenges.
  • White Papers and Case Studies: Benefit quarterly from our in-depth studies related to your purchased titles, tailored to refine your operational and marketing strategies for maximum impact.
  • Annual Updates on Purchased Reports: As an existing customer, enjoy the privilege of annual updates to your reports, ensuring you stay abreast of the latest market insights and technological advancements. Terms and conditions apply.
  • Specialized Focus on Emerging Markets: DataM differentiates itself by delivering in-depth, specialized insights specifically for emerging markets, rather than Product generalized geographic overviews. This approach equips our clients with a nuanced understanding and actionable intelligence that are essential for navigating and succeeding in high-growth regions.
  • Value of DataM Reports: Our reports offer specialized insights tailored to the latest trends and specific business inquiries. This personalized approach provides a deeper, strategic perspective, ensuring you receive the precise information necessary to make informed decisions. These insights complement and go beyond what is typically available in generic databases.

Target Audience 2024

  • Manufacturers/ Buyers
  • Industry Investors/Investment Bankers
  • Research Professionals
  • Emerging Companies

Table of Contents

1. Methodology and Scope

  • 1.1. Research Methodology
  • 1.2. Research Objective and Scope of the Report

2. Definition and Overview

3. Executive Summary

  • 3.1. Snippet by Product
  • 3.2. Snippet by Distribution Channel
  • 3.3. Snippet by Form
  • 3.4. Snippet by Region

4. Dynamics

  • 4.1. Impacting Factors
    • 4.1.1. Drivers
      • 4.1.1.1. Growing Health Awareness
    • 4.1.2. Restraints
      • 4.1.2.1. Supply Chain Constraints and Raw Material Price Volatility
    • 4.1.3. Opportunity
    • 4.1.4. Impact Analysis

5. Industry Analysis

  • 5.1. Porter's Five Force Analysis
  • 5.2. Supply Chain Analysis
  • 5.3. Pricing Analysis
  • 5.4. Regulatory Analysis
  • 5.5. Sustainable Analysis
  • 5.6. DMI Opinion

6. By Product

  • 6.1. Introduction
    • 6.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product
    • 6.1.2. Market Attractiveness Index, By Product
  • 6.2. Vitamins*
    • 6.2.1. Introduction
    • 6.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
    • 6.2.3. Vitamin A
    • 6.2.4. Vitamin B
    • 6.2.5. Vitamin C
    • 6.2.6. Multivitamin
    • 6.2.7. Others
  • 6.3. Minerals
    • 6.3.1. Zinc
    • 6.3.2. Calcium
    • 6.3.3. Others
  • 6.4. Multivitamin/mineral (MVM) supplements

7. By Distribution Channel

  • 7.1. Introduction
    • 7.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Distribution Channel
    • 7.1.2. Market Attractiveness Index, By Distribution Channel
  • 7.2. Hospital Pharmacy*
    • 7.2.1. Introduction
    • 7.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
  • 7.3. Retail Pharmacy
  • 7.4. Online Sales
  • 7.5. Others

8. By Form

  • 8.1. Introduction
    • 8.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Form
    • 8.1.2. Market Attractiveness Index, By Form
  • 8.2. Capsules*
    • 8.2.1. Introduction
    • 8.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
  • 8.3. Tablets
  • 8.4. Powder
  • 8.5. Chewable
  • 8.6. Others

9. By Region

  • 9.1. Introduction
    • 9.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Region
    • 9.1.2. Market Attractiveness Index, By Region
  • 9.2. North America
    • 9.2.1. Introduction
    • 9.2.2. Key Region-Specific Dynamics
    • 9.2.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product
    • 9.2.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Distribution Channel
    • 9.2.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Form
    • 9.2.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 9.2.6.1. US
      • 9.2.6.2. Canada
      • 9.2.6.3. Mexico
  • 9.3. Europe
    • 9.3.1. Introduction
    • 9.3.2. Key Region-Specific Dynamics
    • 9.3.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product
    • 9.3.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Distribution Channel
    • 9.3.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Form
    • 9.3.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 9.3.6.1. Germany
      • 9.3.6.2. UK
      • 9.3.6.3. France
      • 9.3.6.4. Italy
      • 9.3.6.5. Spain
      • 9.3.6.6. Rest of Europe
  • 9.4. South America
    • 9.4.1. Introduction
    • 9.4.2. Key Region-Specific Dynamics
    • 9.4.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product
    • 9.4.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Distribution Channel
    • 9.4.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Form
    • 9.4.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 9.4.6.1. Brazil
      • 9.4.6.2. Argentina
      • 9.4.6.3. Rest of South America
  • 9.5. Asia-Pacific
    • 9.5.1. Introduction
    • 9.5.2. Key Region-Specific Dynamics
    • 9.5.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product
    • 9.5.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Distribution Channel
    • 9.5.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Form
    • 9.5.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 9.5.6.1. China
      • 9.5.6.2. India
      • 9.5.6.3. Japan
      • 9.5.6.4. Australia
      • 9.5.6.5. Rest of Asia-Pacific
  • 9.6. Middle East and Africa
    • 9.6.1. Introduction
    • 9.6.2. Key Region-Specific Dynamics
    • 9.6.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product
    • 9.6.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Distribution Channel
    • 9.6.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Form

10. Competitive Landscape

  • 10.1. Competitive Scenario
  • 10.2. Market Positioning/Share Analysis
  • 10.3. Mergers and Acquisitions Analysis

11. Company Profiles

  • 11.1. AMWAY*
    • 11.1.1. Company Overview
    • 11.1.2. Product Portfolio and Description
    • 11.1.3. Financial Overview
    • 11.1.4. Key Developments
  • 11.2. Lonza Group
  • 11.3. BASF SE
  • 11.4. Koninklijke DSM N.V.
  • 11.5. Du Pont
  • 11.6. Pfizer Inc.
  • 11.7. Nutrilo GmbH
  • 11.8. AIE Pharmaceuticals
  • 11.9. ParkAcre Enterprises
  • 11.10. Aland (Jiangsu) Nutraceutical

LIST NOT EXHAUSTIVE

12. Appendix

  • 12.1. About Us and Services
  • 12.2. Contact Us